NASDAQ: GLSI
Greenwich Lifesciences Inc Stock Ownership - Who owns Greenwich Lifesciences?

Insider buying vs selling

Have Greenwich Lifesciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Snehal PatelCEO and CFO2026-01-131,800$29.83
$53.69kBuy
Snehal PatelCEO and CFO2026-01-122,900$27.54
$79.87kBuy
Snehal PatelCEO and CFO2025-12-314,300$21.36
$91.85kBuy
Snehal PatelCEO and CFO2025-12-302,900$21.73
$63.02kBuy
Snehal PatelCEO and CFO2025-12-184,100$12.62
$51.74kBuy
Snehal PatelCEO and CFO2025-11-254,600$8.37
$38.50kBuy
Snehal PatelCEO and CFO2025-11-0710,600$8.43
$89.36kBuy
Snehal PatelCEO and CFO2025-10-312,300$9.26
$21.30kBuy

1 of 1

GLSI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GLSI insiders and whales buy or sell their stock.

GLSI Shareholders

What type of owners hold Greenwich Lifesciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Snehal Patel65.72%9,646,578$232.10MInsider
Kinnary Patel9.06%1,329,590$31.99MInsider
Kenneth Hallock5.41%794,308$19.11MInsider
David McWilliams4.23%620,301$14.92MInsider
Blackrock Inc2.96%433,860$10.44MInstitution
Eric Rothe2.13%313,226$7.54MInsider
Vanguard Capital Management LLC2.03%298,266$7.18MInstitution
Jaye Thompson1.80%264,148$6.36MInsider
Geode Capital Management LLC1.06%155,466$3.74MInstitution
State Street Corp0.91%133,875$3.22MInstitution

1 of 3

GLSI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GLSI11.60%88.40%Net Buying
AVIR72.84%27.16%Net BuyingNet Buying
ZURA53.91%46.09%Net Buying
VSTM61.89%38.11%Net SellingNet Selling
VNDA52.42%47.58%Net Selling

Greenwich Lifesciences Stock Ownership FAQ

Who owns Greenwich Lifesciences?

Greenwich Lifesciences (NASDAQ: GLSI) is owned by 11.67% institutional shareholders, 88.96% Greenwich Lifesciences insiders, and 0.00% retail investors. Snehal Patel is the largest individual Greenwich Lifesciences shareholder, owning 9.65M shares representing 65.72% of the company. Snehal Patel's Greenwich Lifesciences shares are currently valued at $225.83M.

If you're new to stock investing, here's how to buy Greenwich Lifesciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.